 |
liposomal �}±-galactosylceramide |
|---|---|
| Trade Name | Lip. Alpha Galactosylceramide |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2012-09-28 00:00:00 |
| Sponsor | REGiMMUNE Corporation;320 Logue Avenue;Mountain View, California, 94043 |
